Mandate

Vinge advises EQT VIII in connection with the acquisition of Schülke & Mayr GmbH

September 29, 2020 EU, Competition and Regulatory

Vinge has advised EQT VIII on the merger control aspects of EQT VIII’s acquisition of Schülke & Mayr GmbH, a provider of infection prevention solutions. The acquisition was notified to, inter alia, the European Commission.

Vinge’s team consisted primarily of Emma Johansson and Johan Wahlbom.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026